ARCHIVES

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials

December 31, 2010

Beta Carotene Doesn’t Help, May Hurt, Two Trials Find

January 26, 1996

Obama Reiterates Support For Doubling Budgets For Cancer Research, Other Science Agencies

May 1, 2009

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

November 28, 2014